Compare Panacea Biotech with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs DR. REDDYS LAB - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH DR. REDDYS LAB PANACEA BIOTECH/
DR. REDDYS LAB
 
P/E (TTM) x 17.2 41.6 41.2% View Chart
P/BV x 6.7 5.7 117.3% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 PANACEA BIOTECH   DR. REDDYS LAB
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
DR. REDDYS LAB
Mar-20
PANACEA BIOTECH/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3543,363 10.5%   
Low Rs1382,352 5.9%   
Sales per share (Unadj.) Rs74.61,054.2 7.1%  
Earnings per share (Unadj.) Rs6.7121.9 5.5%  
Cash flow per share (Unadj.) Rs15.5190.2 8.1%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs57.2938.7 6.1%  
Shares outstanding (eoy) m61.25166.17 36.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.32.7 121.7%   
Avg P/E ratio x36.823.4 157.1%  
P/CF ratio (eoy) x15.915.0 105.6%  
Price / Book Value ratio x4.33.0 141.2%  
Dividend payout %020.5 0.0%   
Avg Mkt Cap Rs m15,061474,831 3.2%   
No. of employees `0002.321.7 10.7%   
Total wages/salary Rs m1,47133,802 4.4%   
Avg. sales/employee Rs Th1,973.68,091.0 24.4%   
Avg. wages/employee Rs Th635.61,561.3 40.7%   
Avg. net profit/employee Rs Th176.8935.8 18.9%   
INCOME DATA
Net Sales Rs m4,567175,170 2.6%  
Other income Rs m456,206 0.7%   
Total revenues Rs m4,612181,376 2.5%   
Gross profit Rs m2,03024,421 8.3%  
Depreciation Rs m54011,348 4.8%   
Interest Rs m1,048983 106.6%   
Profit before tax Rs m48618,296 2.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77-1,403 -5.5%   
Profit after tax Rs m40920,260 2.0%  
Gross profit margin %44.413.9 318.8%  
Effective tax rate %15.9-7.7 -206.8%   
Net profit margin %9.011.6 77.4%  
BALANCE SHEET DATA
Current assets Rs m2,415125,991 1.9%   
Current liabilities Rs m9,07772,141 12.6%   
Net working cap to sales %-145.930.7 -474.6%  
Current ratio x0.31.7 15.2%  
Inventory Days Days6573 89.1%  
Debtors Days Days71105 67.7%  
Net fixed assets Rs m8,33383,854 9.9%   
Share capital Rs m61831 7.4%   
"Free" reserves Rs m3,443155,157 2.2%   
Net worth Rs m3,504155,988 2.2%   
Long term debt Rs m4611,304 35.4%   
Total assets Rs m13,755232,253 5.9%  
Interest coverage x1.519.6 7.5%   
Debt to equity ratio x0.10 1,574.5%  
Sales to assets ratio x0.30.8 44.0%   
Return on assets %10.69.1 115.8%  
Return on equity %11.713.0 89.9%  
Return on capital %38.712.6 306.8%  
Exports to sales %20.90-   
Imports to sales %8.10-   
Exports (fob) Rs m954NA-   
Imports (cif) Rs m372NA-   
Fx inflow Rs m1,20384,193 1.4%   
Fx outflow Rs m46739,616 1.2%   
Net fx Rs m73644,577 1.7%   
CASH FLOW
From Operations Rs m1,04929,841 3.5%  
From Investments Rs m-54-4,923 1.1%  
From Financial Activity Rs m-1,011-25,159 4.0%  
Net Cashflow Rs m-20-266 7.4%  

Share Holding

Indian Promoters % 74.5 25.5 292.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 5.4 11.1%  
FIIs % 1.3 35.3 3.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 23.6 15.3 154.2%  
Shareholders   10,259 75,885 13.5%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   NEULAND LABS  WYETH  ABBOTT INDIA  ALEMBIC  PROCTER & GAMBLE HEALTH  

Compare PANACEA BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Asian Paints Rallies 7% Post Q4 Results(09:30 am)

Asian stock markets climbed today after US benchmarks halted a three-day slide, with signs of a strengthening labor market outweighing investors' concerns about rising inflation.

Related Views on News

Most Popular

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

The Worst Sector in the Market(Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


May 14, 2021 10:24 AM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS